Arthur A. Levin, Director of Stoke Therapeutics STOK, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $149.6K. The latest trade was on 06/03.

AL

AL

Arthur A. Levin

Director

Company

Stoke Therapeutics STOK

First filing

23/01/03

Trades

82 trades

Buys / sales

0 / 24

12-month net buying

−$149.6K

Last trade

06/03

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Stoke TherapeuticsSTOK	Open-market sale10b5-1 plan	03/13	03/17	605 sh	$36.80	$22,264	−12.5%
AB Avidity Biosciences	Open-market sale10b5-1 plan	01/21	01/23	1,758 sh	$72.45	$127,367.1	−9.6%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/08/06	25/08/08	107,500 sh	$47.62	$5,119,150	−84.5%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/01/21	25/01/23	1,872 sh	$28.60	$53,539.2	−12.6%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/11/19	24/11/20	3,323 sh	$42.12	$139,964.76	−18.3%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/10/21	24/10/23	5,000 sh	$46.63	$233,150	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/09/19	24/09/20	5,000 sh	$45.73	$228,650	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/08/19	24/08/21	5,000 sh	$45.19	$225,950	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/07/19	24/07/23	5,000 sh	$45.01	$225,050	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/06/20	24/06/21	5,000 sh	$37.59	$187,950	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/06/12–24/06/13	24/06/14	100,000 sh2 trades	$38.08avg.	$3,807,600	−39.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/05/20	24/05/21	5,000 sh	$29.90	$149,500	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/04/19	24/04/22	5,000 sh	$22.82	$114,100	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/04/03	24/04/03	20,000 sh	$27.11	$542,200	−7.3%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/03/19	24/03/21	5,000 sh	$23.97	$119,850	−25.2%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/03/12	24/03/12	27,641 sh2 trades	$22.04avg.	$609,102	−65.1%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/01/22	24/01/23	1,859 sh	$10.13	$18,831.67	−9.6%
AB Avidity Biosciences	Open-market sale	23/03/15	23/03/17	100 sh	$22.01	$2,201	−0.5%
AB Avidity Biosciences	Open-market sale	23/02/14	23/02/15	10,000 sh2 trades	$23.65avg.	$236,524.26	−34.1%
AB Avidity Biosciences	Open-market sale	23/01/12	23/01/17	10,000 sh	$22.00	$220,000	−88.3%